410 Medical develops innovative resuscitation technologies for emergency and critical care.

Avivomed is a Minneapolis-based medical device company developing next-generation neuromodulation therapies

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technologies to treat autoimmune diseases

Cardiosense combines multimodal wearable sensors with AI to noninvasively detect early signs of cardiac disease and guide personalized therapy.

CVRx develops an implantable system that delivers baroreflex activation therapy. IPO in June 2021 (NASDAQ: CVRX).

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

Developer of a system to enhance embolic cerebral protection. Acquired by Edwards Lifesciences (NYSE: EW) in March 2011.

Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes.

Entegrion develops point-of-care hemostasis solutions centered on its Viscoelastic Coagulation Monitor (VCM)

HistoSonics, Inc. is pioneering a novel, non-invasive therapeutic platform based on histotripsy. Acquired by Bezos Expeditions, Wellington K5 Global 2025

iVEAcare is developing next-generation neuromodulation therapies using advanced implantable devices and software

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

RapidPulse is a medical device company developing an innovative, minimally invasive vascular system for treating acute ischemic stroke.

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain

Wesper is a digital health company developing an FDA-cleared, at-home sleep testing platform that delivers clinical-grade diagnostics for sleep disorders
